Today: 30 June 2026
Browse Category

Stock Market 16 January 2026

Eaton stock jumps on HSBC upgrade as data-center power demand grabs the tape

Eaton stock jumps on HSBC upgrade as data-center power demand grabs the tape

New York, January 16, 2026, 13:50 EST — Regular session Eaton Corporation plc shares climbed roughly 3.6% to $345.36 in Friday afternoon trading following HSBC’s upgrade to Buy. The bank also lifted its price target on the power-management firm from $390 to $400. HSBC highlighted Eaton’s “diversified” portfolio and noted its clear “above-market growth prospects,” while downplaying concerns tied to recent softening in the AI supply chain.
16 January 2026
···
Mastercard stock price slips as UK fee-cap ruling adds to pressure on payments giants

Mastercard stock price slips as UK fee-cap ruling adds to pressure on payments giants

New York, Jan 16, 2026, 13:20 ET — Regular session Shares of Mastercard Incorporated slipped on Friday following a UK court decision that strengthened a regulator’s authority to cap certain cross-border card fees, adding to the growing list of policy risks facing payment networks. The stock dipped about 0.1% to $542.22 after earlier falling to $538.60. In London, a High Court judge dismissed Mastercard’s challenge, affirming that Britain’s Payments System Regulator can set price caps on interchange fees, though the exact limits and timeline remain undecided.
16 January 2026
·
ImmunityBio stock jumps 35% as ANKTIVA bladder cancer trial update puts FDA filing in view

ImmunityBio stock jumps 35% as ANKTIVA bladder cancer trial update puts FDA filing in view

New York, Jan 16, 2026, 12:51 PM EST — Regular session ImmunityBio shares jumped about 35% on Friday after the cancer drugmaker reported faster enrollment and stronger interim results in a key bladder cancer study for its ANKTIVA therapy. The stock was up $1.39 at $5.34 by 12:51 p.m. EST after hitting $5.53, with about 133 million shares traded. The company said more than 85% of patients are enrolled in its QUILT-2.005 trial and it is targeting a U.S. filing by the end of 2026; an interim analysis showed 85% of patients on ANKTIVA plus BCG stayed in complete response at six months versus 57% on BCG alone and 84% versus 52% at nine months.
16 January 2026
···
GE Vernova stock jumps 6% as Trump-backed PJM power auction plan targets AI data-center demand

GE Vernova stock jumps 6% as Trump-backed PJM power auction plan targets AI data-center demand

NEW YORK, Jan 16, 2026, 13:14 ET — Regular session Shares of GE Vernova Inc jumped over 6% on Friday following reports that the Trump administration, along with several governors, is pushing for an emergency power auction in the PJM market. Investors took the move as a potential boost for turbine demand. By 12:58 p.m. ET, the stock had climbed 6.1% to $681.57, hitting an intraday peak of $692.49 earlier.
16 January 2026
······
1 … 719 720 721 722 723 … 1,605

Stock Market Today

  • Dycom Industries (DY) gains 12.6% in 12 weeks on momentum signals
    June 30, 2026, 10:23 AM EDT. Dycom Industries (DY) has put up a 12.6% price move over the past 12 weeks and is up 9.1% in the last month, showing steady price momentum for trend-focused investors. Shares are now trading at 96.2% of their 52-week range, which could point to a possible breakout. The stock carries a Zacks Rank #2 (Buy) and sits in the top 20% for earnings estimate revisions and earnings surprises-usually big for short-term swings. It also holds an Average Broker Recommendation of #1 (Strong Buy), often seen as a gauge of positive sentiment. This mix of price strength and solid analyst ratings is keeping DY on the radar of traders looking for momentum setups.
Go toTop